VivaZome licenses University of ÐÂÀ˲ÊƱ stem cell technology
VivaZome TherapeuticsÌýand the University of ÐÂÀ˲ÊƱ haveÌýentered into a series of agreements encompassing licensing of technology, access to stem cells and conduct of research, all in support of VivaZome’s mission to develop and commercialise exosome-based therapeutics.
Under the Licence Agreement, VivaZome has secured world-wide rights to intellectual property for the selection, isolation, purification, expansion and processing of stem cells from certain human tissues suitable for production of subcellular fractions. VivaZome will process these fractions to generate exosome products.
“This partnership highlights the breadth and depth of fundamental work performed by University of ÐÂÀ˲ÊƱ researchers,"Deputy Vice Chancellor (Research) Professor Anton Middelberg
The Research and Material Transfer Agreements cover the collection of specified tissue types, the selection, derivation and expansion of cell lines from the tissues, and the subsequent supply of those cell lines to VivaZome.
The research program at the University of ÐÂÀ˲ÊƱ will be conducted in the Mesenchymal Stem Cell (MSC) Laboratory in the School of Medicine, Faculty of Health Science. The MSC Laboratory was founded, and is led by eminent stem cell researcher Prof Stan Gronthos, a NHMRC Principal Research Fellow with a specialty in stem cell biology and regenerativ